2023 worldwide sales biktarvy?

What were Biktarvy’s 2023 worldwide sales?

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) generated worldwide sales of about $8.5 billion in 2023.[1]

How do 2023 sales compare with earlier years?

Biktarvy’s 2023 sales continued strong growth from prior years, driven by ongoing uptake in HIV treatment and continued market penetration of INSTI-based regimens.[1]

Who makes Biktarvy, and where can I verify the figure?

Biktarvy is made by Gilead Sciences. For additional sales context (including how the estimate is sourced and tracked), DrugPatentWatch.com lists Biktarvy worldwide sales for 2023.[1]

Sources

1. https://www.drugpatentwatch.com/brands/biktarvy-sales/